3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Venous Thromboembolism
15
Venous Thrombosis
11
Pulmonary Embolism
10
Neoplasms
9
Thrombosis
4
Thromboembolism
4
Pancreatic Neoplasms
4
Lung Neoplasms
4
Multiple Myeloma
3
Neoplasm Metastasis
2
Lymphoma
2
Hemorrhage
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Thrombophilia
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms, Plasma Cell
1
Interventions
Pancreaticojejunostomy
4
Octreotide
2
obeticholic acid
1
fludarabine
1
apixaban
1
aldesleukin
1
X-Rays
1
Ursodeoxycholic Acid
1
Tranexamic Acid
1
Tissue Adhesives
1
Tea
1
Surgical Procedures, Operative
1
Stents
1
Specimen Handling
1
Sodium Chloride
1
Rivaroxaban
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Pantoprazole
1
Nutritional Status
1
Nutrition Therapy
1
Irinotecan
1
Iopamidol
1
Hydromorphone
1
Hydrocortisone
1
High-Energy Shock Waves
1
Epinephrine
1
Enteral Nutrition
1
Endoscopy, Gastrointestinal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Duodenal Neoplasms
×
Dalteparin
×
Clear all
NCT03139487
2020-01-06
PRIORITY
Asan Medical Center
Phase 2
Unknown
176 enrolled